Gomita Yutaka, Moriyama Minehiro, Ichimaru Yasuyuki, Araki Hiroaki, Sagara Hidenori
Department of Hospital Pharmacy, Okayama University Medical School, Okayama, 700-8558 Japan.
Nihon Shinkei Seishin Yakurigaku Zasshi. 2004 Jun;24(3):111-8.
In considering characteristics of action of anxiolytic drugs and the mechanism of drug action in the brain, it may be necessary to study not only the behavioral pharmacology but also the brain site. In the present study, anxiolytic drugs have been examined in various kinds of behaviors induced by stimulating the brain areas with regard to emotional expression such as reward (pleasure) or aversion in rats. First, the low rate responding on lateral hypothalamic self-stimulation behavior was induced by schedules of low current brain stimulation, variable interval (VI) and differential reinforcement of low rate (DRL). Anxiolytic drugs such as benzodiazepines facilitated these low rate responses. The drug susceptibility was high in the order of the low current stimulation > VI > DRL schedules. Furthermore, it was found by the auto-titration method on intracranial self-stimulation behavior that anxiolytic drugs decreased the threshold of stimulation reward. Second, it was recognized using the decremental lever pressing (DLP) paradigm that anxiolytic drugs increased the threshold of aversive stimulation of mesencephalic dorsal central gray (DCG), and this increasing effect of the drug was antagonized by GABA receptor blockers such as biccuculline. Third, it has been examined whether the conflict situation is established by combining with brain stimulation reward and aversion such as foot-shock or DCG stimulation. As a result, the conflict behavior was established by combining with not only the brain stimulation reward and foot shock aversion, but also the brain stimulation reward and DCG stimulation aversion. Further anxiolytic drugs exhibited the anti-conflict action to both situations. The susceptibility of anxiolytic drugs to the conflict behavior by intracranial reward and aversion was higher than the conventional method based on milk reward and foot shock aversion. Indeed, in the present brain stimulation behavioral study, anxiolytic drugs such as benzodiazepines increased the stimulation threshold in lateral hypothalamic self-stimulation and inhibited the DCG aversive stimulation, i.e. resulting in an anticonflict action of the drugs. Recently we have preliminarily established a new model for evaluating the drug which may facilitate the motivation contributing to result in various behaviors, using the priming stimulation paradigm in intracranial self-stimulation behavior. Diazepam, benzodiazepine, and nomifensine, an dopamine uptake inhibitor, exhibited a delay of the extinction process which included non-reinforcing stimulation and pretrial electric stimulation (priming stimulation) in the self-stimulation behavior. This action may be related to the brain-mechanism of motivation.
在考虑抗焦虑药物的作用特性以及药物在大脑中的作用机制时,可能不仅有必要研究行为药理学,还需研究脑区。在本研究中,已针对大鼠中与情绪表达相关的脑区(如奖赏(愉悦)或厌恶)受到刺激所诱发的各种行为,对抗焦虑药物进行了检测。首先,通过低电流脑刺激、可变间隔(VI)和低反应率差异强化(DRL)等程序,诱发了下丘脑外侧自我刺激行为的低反应率。苯二氮䓬类等抗焦虑药物促进了这些低反应率。药物敏感性按低电流刺激>VI>DRL程序的顺序依次增高。此外,通过对颅内自我刺激行为的自动滴定法发现,抗焦虑药物降低了刺激奖赏的阈值。其次,使用递减式杠杆按压(DLP)范式发现,抗焦虑药物提高了中脑背侧中央灰质(DCG)厌恶刺激的阈值,并且该药物的这种增强作用被荷包牡丹碱等GABA受体阻滞剂所拮抗。第三,研究了将脑刺激奖赏与厌恶(如足部电击或DCG刺激)相结合是否能建立冲突情境。结果发现,不仅将脑刺激奖赏与足部电击厌恶相结合,而且将脑刺激奖赏与DCG刺激厌恶相结合,均可建立冲突行为。此外,抗焦虑药物对这两种情境均表现出抗冲突作用。抗焦虑药物对颅内奖赏和厌恶所引起的冲突行为的敏感性高于基于乳汁奖赏和足部电击厌恶的传统方法。实际上,在当前的脑刺激行为研究中,苯二氮䓬类等抗焦虑药物提高了下丘脑外侧自我刺激的刺激阈值,并抑制了DCG厌恶刺激,即产生了药物的抗冲突作用。最近,我们初步建立了一种新的模型,用于评估可能促进导致各种行为的动机的药物,该模型采用颅内自我刺激行为中的启动刺激范式。地西泮、苯二氮䓬和多巴胺摄取抑制剂诺米芬辛在自我刺激行为中表现出消退过程的延迟,该过程包括非强化刺激和预试验电刺激(启动刺激)。这种作用可能与动机的脑机制有关。